Novel metastatic burden‐stratified risk model in de novo metastatic hormone‐sensitive prostate cancer

The metastatic burden is a critical factor for decision‐making in the treatment of metastatic hormone‐sensitive prostate cancer (HSPC). This study aimed to develop and validate a novel risk model for survival in patients with de novo low‐ and high‐burden metastatic HSPC. The retrospective observatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiota, Masaki, Terada, Naoki, Kitamura, Hiroshi, Kojima, Takahiro, Saito, Toshihiro, Yokomizo, Akira, Kohei, Naoki, Goto, Takayuki, Kawamura, Sadafumi, Hashimoto, Yasuhiro, Takahashi, Atsushi, Kimura, Takahiro, Tabata, Ken‐ichi, Tomida, Ryotaro, Hashimoto, Kohei, Sakurai, Toshihiko, Shimazui, Toru, Sakamoto, Shinichi, Kamiyama, Manabu, Tanaka, Nobumichi, Mitsuzuka, Koji, Kato, Takuma, Narita, Shintaro, Yasumoto, Hiroaki, Teraoka, Shogo, Kato, Masashi, Osawa, Takahiro, Nagumo, Yoshiyuki, Matsumoto, Hiroaki, Enokida, Hideki, Sugiyama, Takayuki, Kuroiwa, Kentaro, Inoue, Takahiro, Sugimoto, Mikio, Mizowaki, Takashi, Kamoto, Toshiyuki, Nishiyama, Hiroyuki, Eto, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409413/
https://www.ncbi.nlm.nih.gov/pubmed/34145921
http://dx.doi.org/10.1111/cas.15038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409413/
https://www.ncbi.nlm.nih.gov/pubmed/34145921
http://dx.doi.org/10.1111/cas.15038

Ejemplares similares